Structure of human GABABreceptor in an inactive state.
Park, J., Fu, Z., Frangaj, A., Liu, J., Mosyak, L., Shen, T., Slavkovich, V.N., Ray, K.M., Taura, J., Cao, B., Geng, Y., Zuo, H., Kou, Y., Grassucci, R., Chen, S., Liu, Z., Lin, X., Williams, J.P., Rice, W.J., Eng, E.T., Huang, R.K., Soni, R.K., Kloss, B., Yu, Z., Javitch, J.A., Hendrickson, W.A., Slesinger, P.A., Quick, M., Graziano, J., Yu, H., Fiehn, O., Clarke, O.B., Frank, J., Fan, Q.R.(2020) Nature 584: 304-309
- PubMed: 32581365 
- DOI: https://doi.org/10.1038/s41586-020-2452-0
- Primary Citation of Related Structures:  
6WIV - PubMed Abstract: 
The human GABA B receptor-a member of the class C family of G-protein-coupled receptors (GPCRs)-mediates inhibitory neurotransmission and has been implicated in epilepsy, pain and addiction 1 . A unique GPCR that is known to require heterodimerization for function 2-6 , the GABA B receptor has two subunits, GABA B1 and GABA B2 , that are structurally homologous but perform distinct and complementary functions. GABA B1 recognizes orthosteric ligands 7,8 , while GABA B2 couples with G proteins 9-14 . Each subunit is characterized by an extracellular Venus flytrap (VFT) module, a descending peptide linker, a seven-helix transmembrane domain and a cytoplasmic tail 15 . Although the VFT heterodimer structure has been resolved 16 , the structure of the full-length receptor and its transmembrane signalling mechanism remain unknown. Here we present a near full-length structure of the GABA B receptor, captured in an inactive state by cryo-electron microscopy. Our structure reveals several ligands that preassociate with the receptor, including two large endogenous phospholipids that are embedded within the transmembrane domains to maintain receptor integrity and modulate receptor function. We also identify a previously unknown heterodimer interface between transmembrane helices 3 and 5 of both subunits, which serves as a signature of the inactive conformation. A unique 'intersubunit latch' within this transmembrane interface maintains the inactive state, and its disruption leads to constitutive receptor activity.
Organizational Affiliation: 
Department of Pharmacology, Columbia University, New York, NY, USA.